New Delhi: Pfizer announced on Wednesday that talks continues with the Indian government over the possibility of making its COVID-19 vaccine available for use in the government immunisation programme.
The American multinational pharmaceutical corporation’s statement came after Drugs Controller General of India (DCGI) exempted to hold more trials of coronavirus vaccines which have been approved by other international regulatory bodies.
“Pfizer continues to remain engaged with the Government of India towards making its COVID-19 vaccine available for use in the Government immunisation programme in the country. As these discussions are ongoing, we are unable to share any additional details at this time,” a Pfizer spokesperson said.
DCGI has done away with individual trials of coronavirus vaccines that have been sanctioned by other international regulatory bodies – a move which will moist likely clear the way for foreign COVID-19 vaccines like Pfizer and Moderna for the country’s urgent requirement.
In a letter, DCGI Chief VG Somani said that this will be applicable for coronavirus vaccines that have already received approval for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for Emergency Use by the World Health Organisation.
India’s COVID-19 Vaccine Tally
India has so far administered more than 21.8 crore doses of the coronavirus vaccine, the data from the Ministry of Health and Family Welfare showed on Wednesday. A total of 21,85,46,667 doses were given till 7 am on June 2, as per the data. Out of these, 23,97,191 doses were administered in the last 24 hours.
India reported 1,32,788 fresh cases of novel coronavirus in the last 24 hours, as per the Union Ministry of Heath and Family Welfare.
2,31,456 discharges & 3,207 deaths were reported in the last 24 hours, according to the Ministry. The total caseload stands at 2,83,07,832 while the active cases are 17,93,645.
Total 2,61,79,085 recoveries reported across the country so far. The death toll is at 3,35,102. On the vaccination front, a total of 21,85,46,667 doses have been administered so far. A total of 35,00,57,330 samples tested up to June 1, inclusive of data reconciled by the States. Of these, 20,19,773 samples were tested yesterday, as per the Indian Council of Medical Research (ICMR).